TGFβ Pathway Inhibition Redifferentiates Human Pancreatic Islet β Cells Expanded In Vitro.
In-vitro expansion of insulin-producing cells from adult human pancreatic islets could provide an abundant cell source for diabetes therapy. However, proliferation of β-cell-derived (BCD) cells is associated with loss of phenotype and epithelial-mesenchymal transition (EMT). Nevertheless, BCD cells...
Main Authors: | Ginat Toren-Haritan, Shimon Efrat |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4587799?pdf=render |
Similar Items
-
MiR-375 promotes redifferentiation of adult human β cells expanded in vitro.
by: Gili Nathan, et al.
Published: (2015-01-01) -
Transient supplementation of growth factor TGF-β1 effectively initiates chondrogenic redifferentiation of human chondrocytes
by: Hiemer Bettina, et al.
Published: (2017-09-01) -
Insulin-producing cells generated from dedifferentiated human pancreatic beta cells expanded in vitro.
by: Holger A Russ, et al.
Published: (2011-01-01) -
Toward personalized TGFβ inhibition for pancreatic cancer
by: Ryan M Carr, et al.
Published: (2019-11-01) -
Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
by: Milind Javle, et al.
Published: (2014-01-01)